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Abstract. A two-groups mixed-effects model for the comparison of
(normalized) microarray data from two treatment groups is considered.
Most competing parametric methods that have appeared in the litera-
ture are obtained as special cases or by minor modification of the pro-
posed model. Approximate maximum likelihood fitting is accomplished
via a fast and scalable algorithm, which we call LEMMA (Laplace ap-
proximated EM Microarray Analysis). The posterior odds of treatment
× gene interactions, derived from the model, involve shrinkage esti-
mates of both the interactions and of the gene specific error variances.
Genes are classified as being associated with treatment based on the
posterior odds and the local false discovery rate (f.d.r.) with a fixed
cutoff. Our model-based approach also allows one to declare the non-
null status of a gene by controlling the false discovery rate (FDR). It
is shown in a detailed simulation study that the approach outperforms
well-known competitors. We also apply the proposed methodology to
two previously analyzed microarray examples. Extensions of the pro-
posed method to paired treatments and multiple treatments are also
discussed.
Key words and phrases: EM algorithm, empirical Bayes, Laplace ap-
proximation, LEMMA, LIMMA, linear mixed models, local false dis-
covery rate, microarray analysis, mixture model, two-groups model.
1. INTRODUCTION
Microarray technologies have become a major data
generator in the post-genomics era. Instead of work-
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ing on a gene-by-gene basis, microarray technologies
allow scientists to view the expression of thousands
of genes from an experimental sample simultane-
ously. Due to the cost, it is common that thousands
of genes are measured with a small number of repli-
cations, as a consequence, one faces a large G, small
n problem, where G is the total number of genes and
n is the number of replications. After preprocess-
ing of the raw image data, the expression levels are
often assumed to follow a two-groups model, that
is, the expressions are each either null or non-null
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with prior probability p0 or p1 = 1−p0, respectively.
The two-groups model plays an important role in
the Bayesian microarray literature and is broadly
applicable (Efron, 2008).
A general review of issues pertaining to microar-
ray data analysis is provided in Allison et al. (2006).
Here, we focus on statistical inference and, in partic-
ular, on what Allison et al. (2006) refer to as “con-
sensus points 2 and 3”: the advantages of shrinkage
methods, and controlling the false discovery rate.
We review several inferential methods, and develop
a unifying linear model approach.
Classical parametric statistics do not provide a
reliable methodology for determining differentially
expressed genes. The large number of genes with
relatively few replications in typical microarray ex-
periments yield variance estimates of the expres-
sion levels that are often unreliable. The classical
t-test and F -test are generated under a heteroge-
neous error variance model assumption and do not
enjoy the advantage gained by shrinkage estimation.
The assumption that the variances are equal across
all genes is typically not realistic. Hypothesis tests
based on a pooled common variance estimator for all
genes have low power and can result in misleading
differential expression results (Wright and Simon,
2003; Smyth, 2004; Cui et al., 2005).
An important observation is that, although there
are only a few replications for each gene, the total
number of measurements is very large. If informa-
tion is combined across the genes (i.e., genome-wide
shrinkage), it is possible to construct test proce-
dures that have improved performance. The SAM
test (Tusher, Tibshirani and Chu, 2001) and a reg-
ularized t-test in Efron et al. (2001) first used infor-
mation across the genome-wide expression values by
the addition of a data-based constant to the gene-
specific standard errors.
The Bayesian approach seems to be particularly
well suited for combining information in expression
data. Hierarchical Bayesian models have also been
used for variance regularization by estimating mod-
erated variances of individual genes. The estimated
variances are calculated as weighted averages of the
gene-specific sample variances and pooled variances
across all genes. In particular, the regularized t-test
proposed by Baldi and Long (2001) uses a hier-
archical model and substitutes an empirical Bayes
variance estimator based on a prior distribution in
place of the usual variance estimate. Another hier-
archical approach was developed in Newton et al.
(2001) for detecting changes of gene expression in
a two-channel cDNA microarray experiment. This
was extended to replicate chips with multiple condi-
tions using a hierarchical lognormal–normal model
in Kendziorski et al. (2003). A key difference be-
tween these models and those discussed above is that
they effectively induce shrinkage in the mean effects
(i.e., the numerator of the t-statistic), while assum-
ing homogeneous variability across genes.
Instead of directly modeling the variation of the
expression data, two-groups models are character-
ized by mixing measurements over latent gene-specific
indicators. Lonnstedt and Speed (2002) used this
approach to derive the so-called B-statistic as the
logarithm of the posterior odds of differential ex-
pression. Smyth (2004) extended the B-statistic to
the linear models setting and has written the widely
used limma R package (R Development Core Team,
2007). Smyth (2004) also shows that the B-statistic
is a monotone function of a t-statistic with a regu-
larized variance which he refers to as a moderated
t-statistic. Wright and Simon (2003) and Cui et al.
(2005) derive similarly moderated statistics, and Cui
et al. (2005) showed that their proposed test, us-
ing a James–Stein type variance estimator, had the
best or nearly the best power for detecting differen-
tially expressed genes over a wide range of situations
compared to a number of existing alternative proce-
dures.
Since the performance of the F -type test statistics
arising from models with a random gene-specific er-
ror variance (leading to shrinkage estimates of the
error variances) is better than in the case where the
variances are fixed, why only model the variances as
random but not the means? In effect, the approach
of Lonnstedt and Speed (2002), and its extension
in Smyth (2004), already do this by treating both
the gene-specific mean effects and error variances as
random. These models have been further general-
ized by Tai and Speed (2006, 2009) to the multi-
variate setting to handle, for example, short time-
series of microarrays. These authors coined the term
“fully moderated” for such models. However, as we
point out later is Section 4, the specific distribu-
tional assumptions made in these models imply that
the shrinkage factor for the mean effects is the same
for all genes, resulting in performance equivalent to
the ordinary moderated-t.
Hwang and Liu (2010) proposed an alternative
empirical Bayes approach which shrinks both the
means and variances differentially (see also Liu, 2006).
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Their simulation studies indicate that their fully
moderated procedure is more powerful than all the
other tests existing in the literature. The Hwang and
Liu (2010) procedure uses method of moments esti-
mators of some model parameters rather than max-
imum likelihood. The advantage of our EM fitting
algorithm is that it is easily extended to more gen-
eral models, for example, including covariates, or the
three groups mixture model discussed in Section 3.4.
Still, their approach provided the key insight that
motivated the model formulation and subsequent
computational algorithm described in this article.
The development of the empirical Bayes method-
ologies that improve the power to detect differen-
tially expressed genes essentially reduces to the choice
of whether gene-specific effects should be modeled as
fixed or random. This question applies to effects on
both the mean and the error variance. Thus, there
are four combinations of fixed and random factors
leading to four models which we denote by FF, RF,
FR and RR, where the first letter identifies whether
the mean effects are fixed or random and the second
letter does the same for the error variances. Two ad-
ditional models, denoted FH and RH, are obtained
if the error variances are assumed to be homoge-
neous across genes. The FF category corresponds to
the naive approach of applying t- or F -tests to each
gene separately. The FR category includes the mod-
els in Wright and Simon (2003) and Cui et al. (2005).
The gamma–gamma and log-normal–normal models
of Newton et al. (2001) and Kendziorski et al. (2003)
are of the RH type. The approach of Hwang and Liu
(2010) falls in the RR category. Table 1 summarizes
how previously proposed statistics fall into the six
model categories. Note that the RR category also in-
cludes the LIMMA model. However, inference with
the B-statistic of Lonnstedt and Speed (2002) and
Smyth (2004) results in a shrinkage factor for the
mean effects which is the same for all genes. Conse-
quently, LIMMA is therefore similar to an FR-type
model in terms of frequentist performance since the
posterior odds are monotone in the moderated t-
statistic.
In this paper we present a unified modeling frame-
work for empirical Bayes inference in microarray ex-
periments together with a simple and fast EM algo-
rithm for estimation of the model parameters. We
focus on a simple two-condition experimental setup,
but the ANOVA formulation we posit in the next
section allows for easy generalization to more than
two conditions and comparisons based on a single
sample of two channel arrays such as the more gen-
eral designs in Kerr, Martin and Churchill (2000)
and Smyth (2004). The methods of this article can,
in principle, also be extended to a multivariate em-
pirical Bayes model, for example, to analyze short
time-course data as in the extension of theB-statistic
by Tai and Speed (2006, 2009), or to multiple ar-
ray platforms as is used in epigenomic data analysis
(Figueroa et al., 2008).
We apply an approximate EM algorithm for fitting
the proposed model, with the latent null/non-null
status of each gene playing the role of missing data.
The integral needed to evaluate the complete data
likelihood makes direct application of the EM algo-
rithm intractable. However, a simple and accurate
Table 1
Models corresponding to combinations of fixed and random factors
Mean effect Error variance Methods
Fixed Fixed (Heterogenous) t-test/F -test
Fixed Fixed (Homogenous) F3 in Cui and Churchill (2003)
Fixed Random Wright and Simon (2003),
Cui et al. (2005),
Lonnstedt and Speed (2002),
Smyth (2004)
Random Fixed (Heterogenous)
Random Fixed (Homogenous) Newton et al. (2001),
Kendziorski et al. (2003)
Random Random FSS in Hwang and Liu (2010),
Lonnstedt, Rimini and Nilsson (2005),
Tai and Speed (2009),
Lonnstedt and Speed (2002),
Smyth (2004)
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approximation is obtained via the Laplace approx-
imation (de Bruijn, 1981, Chapter 4; Butler, 2007,
page 42). This approximation makes the EM algo-
rithm scalable, tractable, and extremely fast. Imple-
mentation of Bayesian microarray models typically
involves drawing MCMC samples from the poste-
rior distribution of effects from all genes. MCMC
sampling provides a mechanism to study the full
Bayesian posterior distribution. However, there is a
heavy computational burden that makes the MCMC
implementation less attractive. The Laplace approx-
imation circumvents the generation of the thousands
of gene effect parameters and gives a highly accurate
approximation to the integral in the expression of
the complete data likelihood. The Laplace approx-
imated EM algorithm based analysis is the inspi-
ration of the acronym LEMMA (Laplace approxi-
mated EM MicroarrayAnalysis) for the contributed
R package, lemma (Bar and Schifano, 2009), which
implements the methodology described in this pa-
per.
The paper is organized as follows. In Section 2
we introduce the necessary notation for our two-
groups model along with the prior distribution spec-
ifications. Section 3 describes the approximate EM
algorithm for fitting the RR model. We also pro-
pose a generalization of the LIMMAmodel and show
how the EM algorithm is easily modified to estimate
its parameters, and we briefly discuss extensions to
multiple treatments and to a three-groups model. In
Section 4 we show that the posterior probability that
a gene is non-null is a function of a fully-moderated
(in the sense of Hwang and Liu, 2010) posterior t-
statistic with shrinkage in both the numerator and
the denominator. We show that our RR framework
generalizes several other statistics, and describe two
inferential procedures, one based on the posterior
probability that a gene is non-null, and one which is
based on the null distribution and the FDR proce-
dure. Section 5 gives results of a simulation study in
which we compare the performance of various meth-
ods to the “Optimal Rule” procedure based on full
knowledge of the true model and its parameters. Our
proposed methodology is applied to two well-known
microarray examples: the ApoA1 data (Callow et
al., 2000) and the Colon Cancer data (Alon et al.,
1999) in Section 6. We conclude the article in Sec-
tion 7 with a discussion.
2. MODEL AND NOTATION
Let yijg denote the response (e.g., log expression
ratio) of gene g, for subject (replicate) j, in treat-
ment group i= 1,2. We begin with the linear model,
yijg = µ+ τi + γg +ψig + εijg,(1)
with a typical assumption concerning the errors be-
ing
εijg ∼ i.i.d. N(0, σ2ε,g)(2)
for j = 1, . . . , nig, independently across genes and
treatment groups. We impose the identifiability con-
straints, τ1 + τ2 = 0 and ψ1g + ψ2g = 0 for all g =
1, . . . ,G. Then τ = τ1− τ2 is the main effect of treat-
ment, averaged across genes, and ψg = ψ1g − ψ2g ,
g = 1, . . . ,G, are the gene specific treatment effects.
Note that we do not assume that the mean treat-
ment effect is zero. While assuming τ = 0 is often
reasonable when performing differential gene expres-
sion analysis on large microarray data sets, we find
this to be not only an unnecessary constraint, but
also unrealistic in certain situations. For example,
when a data set consists mostly of genes that are
known to be differentially expressed, or when com-
paring expression levels across species (where “treat-
ment” is interpreted as “species”), there is no reason
to assume that the overall mean difference between
the two treatment groups is zero.
We further suppose that the genes fall into two
groups, a null group in which ψg ≡ 0 and a non-
null group in which ψg 6= 0. The primary goal is
to classify genes as null or non-null based on the
observed responses. A probabilistic approach is to
suppose that each gene has prior probability p1 of
being non-null (and p0 = 1−p1 of being null) and to
use Bayes rule to determine the posterior probability
given the data; specifically,
p1,g(yg) =
p1f1,g(yg)
p0f0,g(yg) + p1f1,g(yg)
,(3)
where f1,g(yg) is the probability density of the re-
sponses for gene g implied by the non-null model,
and f0,g(yg) is the corresponding quantity if the gene
is in the null group.
In practice, of course, the mixture probability and
the parameters that determine the null and non-null
densities have to be estimated. This estimation step
depends upon additional assumptions, if any, that
are made about the distribution of the responses.
As noted in the Introduction, a basic question is
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whether gene-specific effects should be modeled as
fixed or random, leading to the model categories
we denote by FF, RF, FR and RR, and two addi-
tional models, FH and RH, obtained when the error
variances are assumed to be homogeneous, that is,
σ2ε,g ≡ σ2ε .
The ANOVA model (1) together with the distri-
butional assumption (2) allows us to restrict at-
tention to the sum and difference of gene-specific
treatment means, respectively, sg = y¯1·g + y¯2·g and
dg = y¯1·g − y¯2·g, and the gene-specific mean squared
errors,
mg =
2∑
i=1
nig∑
j=1
(yijg − y¯i·g)2/fg,
where fg = n1g+n2g−2. Notice that sg|g ∼N(2µ+
2γg, σ
2
g), where σ
2
g ≡ σ2ε,g(1/n1g +1/n2g), and |g de-
notes conditioning on any gene-specific random ef-
fects. It follows that sg carries no information about
the gene-specific treatment effect ψg. For this rea-
son, our estimation procedures use only the marginal
likelihood based on the data ({dg},{mg}). The model
(1) together with assumption (2) also implies that dg
and mg are conditionally independent, with dg|g ∼
(1− bg)N0+ bgN1 independently of mg|g ∼ σ2ε,gχ2fg/
fg, where bg, g = 1, . . . ,G, denotes independent
Bernoulli(p1) latent indicators of non-null status for
the G genes, N0 and N1 denote normal variates with
unequal means τ and τ + ψg 6= τ respectively, but
equal variances σ2g , and χ
2
fg
denotes a chi-squared
variate with fg degrees of freedom.
The family of parametric models considered in
this paper is completed by specifying distributions
for the gene-specific effects, {ψg} and {σ2ε,g}. In what
follows we suppose that, if the (non-null) gene-specific
effects are modeled as random variates, they follow
a normal distribution,
ψg ∼ i.i.d. N(ψ,σ2ψ).(4)
On the other hand, if the gene-specific variances are
modeled as random variates, they are drawn from
an inverse gamma distribution,
σ−2ε,g ∼ i.i.d.Gamma(α,β),(5)
where α and β are shape and scale parameters. We
refer to the RR model specified by (1), (2) and (5)
with the non-null gene-specific effects (4) as the
LEMMA model.
It is worth contrasting (4) with the corresponding
assumption in the models leading to the B-statistic
given in Lonnstedt and Speed (2002) and Smyth
(2004), where the mean of the random effects dis-
tribution is assumed to be zero. In a classical (one
group) normal mixed-model, the mean of the ran-
dom effect is assumed to be zero because it is not
separately identifiable from the overall mean. How-
ever, in the two-groups setting in which ψg in (1)
is modeled as a mixture, assuming ψ 6= 0 in (4)
poses no such identifiability problems. Furthermore,
this additional parameter allows for two useful and
important extensions of the model: (a) to paired
(within-group) analyses, and (b) to three-groups al-
lowing for over- and under-expressed non-null sta-
tus. These extensions are described in more detail
in Section 3.4.
3. ESTIMATION
In this section we describe in detail an approxi-
mate EM algorithm for fitting the LEMMA model.
Estimation for the other five models can be carried
out by making appropriate modifications to this al-
gorithm. The LEMMA model has six parameters,
two being the shape and scale of the distribution for
the error variances given in (5). The remaining vec-
tor of parameters is (p1, τ,ψ,σ
2
ψ) which we denote
by φ.
Estimates of the hyperparameters, α and β, are
obtained by maximizing the marginal likelihood based
on {mg}, given by
L({mg})
=
G∏
g=1
∫
∞
0
f(mg|σ2ε,g)f(σ−2ε,g)dσ−2ε,g
(6)
=
G∏
g=1
m
fg/2−1
g (fg/2)
fg/2
Γ(fg/2)Γ(α)βα
· Γ(fg/2 +α)
(mgfg/2 + 1/β)fg/2+α
.
In practice, we find the maximum likelihood esti-
mates for α and β using the nlminb function in
R. In all the simulations and case studies the func-
tion converged quickly. Since the marginal likelihood
is based on the statistics {mg}, the computation
time depends only on the number of genes, G, but
not on the sample sizes. We have also derived and
implemented moment estimators [similar to Smyth
(2004), who comments that {mg} follow a scaled
F -distribution], and we found that both methods
provide accurate estimation of α and β.
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3.1 EM Algorithm
We apply the EM algorithm to estimate φ, with
the latent indicators, {bg}, playing the role of the
missing data. Since dg and mg are conditionally in-
dependent given (bg, σ
2
ε,g), the complete data likeli-
hood for φ based on ({bg},{dg},{mg}) is
LC(φ) =
G∏
g=1
∫
L(bg, dg;σ
2
ε,g)
(7)
·L(mg;σ2ε,g)f(σ−2ε,g )dσ−2ε,g ,
where f(σ−2ε,g) represents the gamma density with
shape α and scale β.
The integral in (7) makes direct application of the
EM algorithm intractable. However, a simple and
accurate approximation is obtained via the Laplace
approximation (de Bruijn, 1981, Chapter 4; Butler,
2007, page 42)
LC(φ)≈ L˜C(φ)≡
G∏
g=1
L(bg, dg; σ˜
2
ε,g)L(mg; σ˜
2
ε,g)
(8)
·f(σ˜−2ε,g )
√
−2π/ℓ′′(mg; σ˜2ε,g),
where ℓ′′(mg;σ
2
ε,g) is the second derivative of
logL(mg;σ
2
ε,g) with respect to σ
2
ε,g, and σ˜
2
ε,g is the
posterior mode of σ2ε,g given mg, given by
σ˜2ε,g =
fg/2
fg/2 + α+1
mg
(9)
+
α+ 1
fg/2 +α+1
· 1
(α+1)β
.
Notice that the last three factors on the right-side of
(8) do not involve the parameter φ and can therefore
be ignored in the implementation of EM. In practice,
we replace α and β by their maximum likelihood
estimates obtained from the marginal likelihood in
(6).
Denote the estimate after m iterations of EM by
φ(m). The (m + 1)st E-step consists of taking the
conditional expectation of the logarithm of (7) given
the observed data, using the current estimate, φ(m).
Using the Laplace approximation (8), this is given
by
Q(φ,φ(m))
=Eφ(m) [logLC(φ)|{dg},{mg}]
≈Eφ(m) [log L˜C(φ)|{dg},{mg}]
=
G∑
g=1
Eφ(m){logL(bg, dg; σ˜2ε,g)|dg}+C(10)
=
G∑
g=1
{p(m)0,g log[p0f0,g(dg)]
+ p
(m)
1,g log[p1f1,g(dg)]}+C
≡ Q˜(φ,φ(m)) +C,
where C does not depend on φ, f0,g and f1,g denote
N(τ, σ˜2g) and N(τ +ψ,σ
2
ψ + σ˜
2
g) densities with σ˜
2
g =
σ˜2ε,g(1/n1g+1/n2g), p1,g =E(bg|dg) and p0,g+p1,g =
1.
The M-step at the (m+1) iteration requires maxi-
mization of Q˜(φ,φ(m)) with respect to φ to yield the
updated estimate φ(m+1). That is,
φ(m+1) = argmax
φ
Q˜(φ,φ(m)).
This leads to the following maximum likelihood es-
timate update equations for p1, τ and ψ:
p
(m+1)
1 =
1
G
G∑
g=1
p
(m)
1,g ,(11)
τ (m+1) =
∑G
g=1 p
(m)
0,g dg/σ˜
2
g∑G
g=1 p
(m)
0,g /σ˜
2
g
(12)
and
ψ(m+1)
(13)
=
∑G
g=1 p
(m)
1,g (dg − τ (m+1))/(σ2(m)ψ + σ˜2g)∑G
g=1 p
(m)
1,g /(σ
2(m)
ψ + σ˜
2
g)
,
while the update for σ2ψ is the solution of the equa-
tion
G∑
g=1
p
(m)
1,g
1
σ2ψ + σ˜
2
g
(14)
=
G∑
g=1
p
(m)
1,g
(dg − τ (m+1) −ψ(m+1))2
(σ2ψ + σ˜
2
g)
2
,
and σ2ψ = 0 if p1,g = 0 for all the genes.
Strictly speaking, the update for ψ in (13) is con-
ditional on the current value of σ2ψ . However, we
have found this variant of EM to have almost iden-
tical convergence properties to the full EM in which
Q˜ is maximized jointly with respect to all four com-
ponents of φ.
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3.2 Modifications for RF, RH, FF, FH, FR
LEMMA is considered an RR model because the
gene-specific effects (ψg, σ
2
ε,g) are modeled as ran-
dom variates. By considering one or both of these as
fixed effects, we obtain models that fall into one of
the RF, RH, FR, FF or FH categories. Henceforth,
the category labels RF, RH, FF, FH, FR refer to
the models derived from the LEMMA (RR) model
with the corresponding fixed/random distributional
assumption modifications.
The complete data likelihood for the RF model is
LC(φ)≈
G∏
g=1
L(bg, dg;σ
2
ε,g)L(mg;σ
2
ε,g).(15)
Since no integration is required to evaluate this like-
lihood, the Laplace approximation is not needed in
this case. As with the LEMMA (RR) model, we first
estimate the error variances, {σ2ε,g}, separately us-
ing the marginal likelihood for {mg}. This results
in the simple estimate, σˆ2ε,g = mg. The EM algo-
rithm for estimating φ then proceeds in an iden-
tical manner except that σ˜2g is replaced by σˆ
2
g =
σˆ2ε,g(1/n1g+1/n2g). The algorithm for the RHmodel
is also similar with the marginal likelihood estima-
tor of the homogeneous error variance given by σˆ2ε =∑
gmgfg/
∑
g fg.
For all the fixed gene-specific effects models (FR,
FF and FH) it is easily verified that dg − τ (m) −
ψ
(m)
g = 0. This implies that the EM update for the
mixing parameter satisfies
p
(m+1)
1
=
1
G
G∑
g=1
p
(m)
1
p
(m)
0 exp{−(dg − τ (m))2/2σˆ2e,g}+ p(m)1
> p
(m)
1 ,
where σˆ2e,g represents the appropriate σ
2
g estima-
tor for the desired model. As a result, the EM se-
quence for p1 always converges to 1, regardless of
the starting value. An explanation for this behavior
is that the mixture probability is not identifiable if
the gene-specific effects are fixed.
3.3 A Generalization of LIMMA
The LIMMA model proposed by Smyth (2004)
is similar to the LEMMA model described in Sec-
tion 2. A key difference is the assumption concerning
the random gene-specific effects given in (4). The
corresponding assumption in LIMMA is ψg|σ2ε,g ∼
N(0, v0σ
2
ε,g). This assumption, combined with (5),
results in a closed form expression for the complete
data likelihood (7), rendering the use of the Laplace
approximation unnecessary. Another difference is that
the mean effect of treatment, averaged across genes
(τ ), is assumed to be zero in the LIMMA model.
However, this difference has little bearing on the ar-
guments that follow.
As noted in Section 2, it is unnecessary to assume
that the mean of the non-null gene-specific effects,
ψ, is zero. Hence, we consider a generalized LIMMA
model (denoted by RG in what follows) with
ψg|σ2ε,g ∼N(ψ,v0σ2ε,g)(16)
for the non-null gene-specific effects, and, as such, it
falls into the RR category. The EM algorithm dis-
cussed earlier in this section can be implemented
to fit this generalized model with minor modifica-
tions. Specifically, after using the Laplace approxi-
mation, the Q-function has the same form as (10)
with v0,gσ˜
2
ε,g replacing σ
2
ψ + σ˜
2
g as the variance in
the non-null density f1,g, where v0,g = v0 + 1/n1g +
1/n2g . This leads to update equations for p1 and τ
identical to (11) and (12), respectively. The update
for ψ is
ψ(m+1) =
∑G
g=1 p
(m)
1,g (dg − τ (m+1))/(v0,gσ˜2ε,g)∑G
g=1 p
(m)
1,g /(v0,gσ˜
2
ε,g)
,
and the update of v0 satisfies
G∑
g=1
p
(m)
1,g
1
v0,g
=
G∑
g=1
p
(m)
1,g
(dg − τ (m+1) −ψ(m+1))2
v20,gσ˜
2
ε,g
,
and v0 = 0 if p1,g = 0 for all the genes. These updates
simplify further if the sample sizes are the same for
all genes.
3.4 Model Extensions
The LEMMA model is easily extended in a num-
ber of useful ways. First, it enables within-group
analysis which follows the same estimation proce-
dure by simply dropping the i index and combin-
ing the terms µ and τ . We found this to be use-
ful in practical applications, when, for example, re-
searchers wish to perform a paired-sample test.
Similarly, we can extend the model to have multi-
ple treatment groups and test different (user-defined)
contrasts, as was done in Smyth (2004) for the LIMMA
model. Mathematically, this generalization is very
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simple, and, in practice, when dealing with a small
or moderate number of treatment groups, the es-
timation procedure poses no significant computa-
tional challenges. For example, we use the (t − 1-
dimensional vector) summary statistics dg =HY¯g,
where H is a contrast matrix (e.g., the Helmert ma-
trix) and Y¯g = (Y¯1·g, Y¯2·g, . . . , Y¯t·g)
′. Note that the
2 × 2 Helmert matrix gives the dg and sg statis-
tics for the one-treatment case [scaled by a factor of
1/
√
2]. Obtaining the estimates and test statistics
in the multiple treatment case is analogous to the
derivations in (3.1). See the Appendix for details.
As noted in Zhang, Zhang and Wells (2010), it is
often the case that the probabilities of under- and
over-expressed genes are not equal. The assumption
that the distribution of the non-null genes has a
nonzero mean (ψ) can be modified to allow for multi-
ple non-null components in the mixture distribution.
For example, we might assume that each gene is ei-
ther in the null group (ψg = 0) with probability p0,
in one non-null component with probability p1 with
ψg ∼ i.i.d. N(ψ,σ2ψ), or in a second non-null group
with probability p2 with ψg ∼ i.i.d. N(−ψ,σ2ψ), where
p0 + p1 + p2 = 1. The two-component model in the
previous sections is the special case in which p2 = 0.
The lemma R package uses the three component mix-
ture by default, and we have found that, indeed,
when there are two mixture components, the EM
algorithm converges to pˆ2 = 0. Note that the R im-
plementation assumes that the means of the non-
null groups are of the same magnitude but opposite
sign. This assumption can be relaxed, for instance,
by assuming only that ψ1 < 0<ψ2.
4. INFERENCE
The posterior probability that gene g is non-null
is given by the expression (3). Its estimated value
based on the LEMMA model can be expressed as a
function of the likelihood ratio
L0,g
L1,g
≡ fˆ0,g
fˆ1,g
= (2πσ˜2g)
−1/2 exp{−(dg − τˆ)2/2σ˜2g}
/([2π(σˆ2ψ + σ˜
2
g)]
−1/2
· exp{−(dg − τˆ − ψˆ)2/2(σˆ2ψ + σ˜2g)})(17)
=
(
σ˜2g
σˆ2ψ + σ˜
2
g
)
−1/2
· exp
{
−1
2
[λˆg(dg − τˆ) + (1− λˆg)ψˆ]2
λˆgσ˜2g
+
ψˆ2
2σˆ2ψ
}
∝
(
σ˜2g
σˆ2ψ + σ˜
2
g
)
−1/2
exp
{
−1
2
T 2g
}
,
with the constant of proportionality being exp(ψˆ2/
2σˆ2ψ), where
λg =
1
σ2g
(
1
σ2g
+
1
σ2ψ
)
−1
=
σ2ψ
σ2ψ + σ
2
g
.
The statistic Tg is a posterior t-statistic, being the
ratio of the estimated posterior expectation of ψg
to its estimated posterior standard deviation. Note
that the LEMMAmodel induces three forms of shrink-
age in Tg. The first two forms come from λˆg > 0 in
both the numerator and the denominator. Third,
σ˜2g , a function of the posterior mode σ˜
2
ε,g, is itself a
shrinkage estimator as a weighted compromise be-
tween the usual error variance estimator mg and
the mode of the inverse gamma distribution [(α +
1)β]−1.
The likelihood ratio in (17) has the same form
for the RF and RH models with σ˜2ε,g replaced by
σˆ2ε,g and σˆ
2
ε , respectively in σ˜
2
g . [Recall that σ
2
g =
σ2ε,g(1/n1g+1/n2g).] Test statistics for the fixed mean
effects models, FR, FF and FH, are obtained as lim-
its of Tg as λˆg→ 1.
It is interesting to compare the likelihood ratio
(17) with the corresponding statistic under the
LIMMA and RGmodel assumptions discussed in the
previous section. For these models σ2ψ is replaced by
v0σ˜
2
ε,g, and so the shrinkage coefficient becomes
λg =
v0
v0 +1/n1g +1/n2g
.
In particular, if the sample sizes are the same for
all genes, then the amount of shrinkage is the same
for all genes. Furthermore, if ψ is set equal to zero,
as it is in LIMMA, then Tg is proportional to the
test-statistic for the FR model,
Tg =
dg − τˆ
σ˜g
.
This has the same form as the moderated t-statistic
of Smyth (2004) and Wright and Simon (2003) ex-
cept for the subtraction of the average gene effect,
τ , in the numerator and the use of the mode rather
than the expected value of the posterior distribution
of σ2ε,g given mg in the denominator.
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For inference, we compare the posterior null prob-
ability, 1− p1,g in (3), with a local f.d.r. threshold
to decide whether a gene is in the non-null group.
Alternatively, our model-based approach also allows
one to declare the non-null status of a gene by con-
trolling the false discovery rate (FDR), using the
Benjamini and Hochberg (1995) (BH) procedure for
any given level, q∗. Specifically, using the theoretical
null-gene distributions of {dg}, which are assumed
to be N(τˆ , σ˜2g), we obtain the p-values for the ob-
served {dg}. We denote the p-values by {Pg}, and
find the largest index g′ for which PFg′ ≤ q∗ × g′/G,
where {PFg } is the sorted list of p-values. We declare
all the genes with index smaller than or equal to g′
(in the sorted list) as non-null, and the FDR the-
orem guarantees that the expected false discovery
rate is bounded by q∗.
5. SIMULATION STUDY
In this section we assess the performance of several
estimation/testing procedures mentioned in this pa-
per under two data generation models, one accord-
ing to the LEMMA model and the other accord-
ing to the LIMMA model. In practice, the correct
model is unknown, so our goal is to compare the
power, accuracy, false discovery rate and parameter
estimation for different true-model/procedure com-
binations. In what follows we use the term “proce-
dure” to define the combination of the model se-
lected for analysis (which may or may not be the
true model) and the estimation and inferential tech-
niques derived from this model.
5.1 Data Generation
In both scenarios (LEMMA and LIMMA), we sim-
ulated S = 100 data sets according to a mixture
model with two groups, null and non-null. Each data
set consisted of G= 2000 genes, of which p1G were
non-null, and we used p1 = 0.01,0.05,0.1,0.25. For
each of the S data sets we drew G inverse gamma
error variates with shape α and scale β. By vary-
ing α and β, we adjusted the amount of error vari-
ance variability present in the data. The values of
α, β, n1g ≡ n1, and n2g ≡ n2 were chosen so that
mean(σ2g) = 1. With n1 = n2 = 6, we set α = 5 and
β = 1/12 for the “low” error variance variability; we
set α= 2.1 and β = 10/33 for the “high” error vari-
ance variability. Hence, the standard deviation (and
also the coefficient of variation, CV) of σ2g for the
former was 1/
√
3, and for the latter was
√
10.
In the LEMMA-generated data, we varied ψ, so
that ψ ∈ {0,1,2, . . . ,6} ≡ Ψ, and set σ2ψ = 1. In the
LIMMA data generation setup, we used v0 ∈ {16 , 26 ,
. . . , 86} to generate the non-null genes according to
(16). For both generation schemes we set τ = 0, as
the LIMMA model does not involve τ , and it is only
estimable under the random gene by treatment in-
teraction effect models (RR, RF, RH). We gener-
ated yijg according to equations (1) and (2) with
the above parameter specifications, and computed
{dg} and {mg}. While we only present results for
a selection of specific parameter value settings, nu-
merous simulations were performed with a variety
of sample sizes ni, i= 1,2, non-null probabilities p1,
and gene-specific treatment variances σ2ψ. In addi-
tion, we also considered using the log-normal dis-
tribution to generate the error variance σ2ε,g rather
than the inverse gamma distribution. We found the
results to be qualitatively insensitive to these dif-
ferent settings, and the results presented below por-
tray an accurate summary of the performance of the
methods.
5.2 Data Analysis and Results
We consider two metrics for determining null and
non-null status of genes. The first method is based
on computing empirical quantile critical values. Since
the distribution of many of our test statistics is un-
known, we defined a test-specific critical value, Tc,
as the 0.95 quantile among the 1900×100 null genes.
By design, this resulted in an average size of 0.05 for
each test. The average power for each procedure was
determined by the proportion of non-null genes cor-
rectly declared non-null based on the (test-specific)
empirical critical value Tc. Figure 1 shows the av-
erage power (on the logit scale) of the likelihood
ratio tests derived assuming the FF, FH, FR, RF,
RH and RR models, with estimation procedures as
described in Section 3. Also included in our com-
parison were the RG likelihood ratio tests, derived
from the model defined in Section 3.3, and the mod-
erated t-tests obtained from the limma R package.
Since in our simulations we know the exact values
of the parameters, we also included the “Optimal
Rule” statistics (denoted by OR) which were ob-
tained by plugging in the true parameter values in
the likelihood ratio statistic for the true data gener-
ation model (either LEMMA or LIMMA).
When the data are generated according to the
LEMMA model our simulations show that the tests
derived from the RR model achieved the highest
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Fig. 1. Average power (on the logit scale) for empirical quantile analysis under the RR data generation model, with
n1 = n2 = 6, S = 100 samples, G= 2000 genes, and p1 = 0.05 probability of non-null status. Left: low error variance variability
(CV = 0.58). Right: high error variance variability (CV = 3.16).
power for all ψ ∈ Ψ (and almost identical to the
Optimal Rule’s), as can be seen in Figure 1. When
the data are generated according to the LIMMA
model, the likelihood ratio tests derived from the RR
and RG models have nearly identical performance in
terms of power as those of the moderated-t statistics
and the LIMMA Optimal Rule for all values of v0
(figure not shown).
As expected, our simulations also showed that the
average power in the homogeneous error variance
models (RH, FH) decreases as the error variance
variability increases. In general, the random gene
models (RR, RF, RH) demonstrate higher average
power than their corresponding fixed gene counter-
parts. Notice also that the performance of moderated-
t and the FR statistics are almost identical.
The second performance assessment method did
not require computing empirical quantiles, and was
based on local f.d.r. criteria. Efron et al. (2001) and
Efron (2005) defined local f.d.r. as
f.d.r.(yg) = Pr(null |Y = yg)(18)
for the posterior probability of a gene g being in the
null group. Note that this is precisely 1− p1,g(yg),
where p1,g(yg) is given by (3). Since p1 can only
be estimated in the random-mean models, we only
considered the local f.d.r. statistics associated with
RR, RF and RH. For comparison, we also considered
the local f.d.r. statistics for RG and the Optimal
Rule, and two types of B statistics computed by the
limma package to differentiate between those com-
puted with the default value of p1 = 0.01 [referred to
as “Limma(0.01)”] and those computed with the es-
timated value of p1 [referred to as “Limma(pˆ1)”]. We
also included local f.d.r. statistics computed from
the locfdr (Efron, Turnbull and Narasimhan, 2008)
R package (referred to as “Efron” for simplicity).
To evaluate the performance of these procedures,
we looked at two complementary metrics. The first is
the measure of accuracy, defined by the ratio (TP +
TN )/(P +N) as in Hong (2009), where P and N
are the total numbers of non-null and null genes,
respectively, and TP + TN is the sum of correct
classifications (true positives plus true negatives).
The second metric is the false discovery rate, defined
by FP/(FP + TP), where FP is the total number
of false positives. Clearly, our goal is to maximize
the accuracy while maintaining a low false discovery
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Fig. 2. Accuracy (left) and false discovery rate (right) for data generated under the LEMMA model with n1 = n2 = 6, S = 100
samples, G= 2000 genes, and ψ = 3, p1 = 0.05 probability of non-null status, and high error variance variability (CV = 3.16).
rate. To compare different methods, we computed
the accuracy and FDR for a range of posterior null
probability thresholds (between 0 and 0.5). A gene is
declared as non-null if its posterior null probability
is below the selected threshold. Note that when the
threshold is 0, all genes are declared as null and we
obtain accuracy of 1−p1. As we increase the thresh-
old, the total number of detections increases, and if
we let the threshold be 1, all genes are declared as
non-null (and the accuracy is p1).
Figures 2 and 4 demonstrate that when the data
are generated under the LEMMA model, the RR
procedure achieves the highest level of accuracy for
any posterior probability threshold in the range [0,
0.5], and is practically the same as the Optimal Rule.
It has only a slightly higher FDR, compared with
the Optimal Rule. Note that RF has high accuracy,
but very high FDR, indicating it is too liberal and
declares too many genes as non-null.
We also observe that the RR and RG procedures
are quite similar, which is an indication that the
choice of the non-null variance model (either σ2ψ as
in LEMMA, or v0σ
2
ε,g as in LIMMA) does not have
a significant impact on the performance. We also
notice that when the limma package is used with
the estimated value of p1, instead of the default, the
accuracy is greatly improved, with a relatively small
increase in FDR. Still, the RR procedure (under the
LEMMA data generation scheme) is clearly superior
to all other methods.
Interestingly, when the data are generated under
the LIMMA model, we get similar results—the RR
procedure achieves higher accuracy, and only a rel-
atively small increase in false discoveries (see Fig-
ures 3 and 5). It is also interesting that the limma
procedure does not achieve the performance of its
Optimal Rule, and we believe this is due to inaccu-
rate estimation of p1, as demonstrated below. Note
that lemma uses maximum likelihood estimation for
all the model parameters, while limma uses ad-hoc
methods to estimate p1 and v0. In summary, lemma
and its RG variant are competitive with limma when
LIMMA is the true data generating model, but they
are clearly superior when LEMMA is the true data
generating model. Furthermore, the additional pa-
rameters (τ,ψ) in the LEMMA model do not add
to the computational complexity, as the maximum
likelihood estimators are obtained via a simple, and
fast EM algorithm.
To conclude this subsection, we remark that al-
though it is possible to compute posterior probabil-
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Fig. 3. Accuracy (left) and false discovery rate (right) for data generated under the LEMMA model with n1 = n2 = 6, S = 100
samples, G= 2000 genes, and ψ = 3, p1 = 0.25 probability of non-null status, and high error variance variability (CV = 3.16).
Fig. 4. Accuracy (left) and false discovery rate (right) for data generated under the LIMMA model with n1 = n2 = 6, S = 100
samples, G= 2000 genes, and v0 = 1, p1 = 0.05 probability of non-null status, and high error variance variability (CV = 3.16).
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Fig. 5. Accuracy (left) and false discovery rate (right) for data generated under the LIMMA model with n1 = n2 = 6, S = 100
samples, G= 2000 genes, and v0 = 1, p1 = 0.25 probability of non-null status, and high error variance variability (CV = 3.16).
ities using the limma package (which involves plug-
ging in the estimates for v0 and p1), in practice,
inference via the limma package is often frequentist
in nature (using the p-values, computed from the
t-statistics, returned by the eBayes function).
5.3 Estimation Performance
We also analyzed the parameter estimation per-
formance of the lemma software, and we found it to
be very accurate when the data are generated under
the LEMMA model. However, since this is not un-
expected, we chose to present a more interesting re-
sult. Recall that both LEMMA and LIMMA require
estimation of the non-null prior probability, p1. We
compared the estimation of this important param-
eter under those two data generation models using
four estimation methods, including lemma, convest
(from the limma package) and two estimation proce-
dures available in the locfdr package—denoted by
EF-MLE and EF-CME. Smyth (2004) argues that
the mixture proportion parameter is difficult to es-
timate in the model leading to the B-statistic, and
our simulations verify that the estimates of p1 pro-
duced by the limma package are significantly biased.
(As noted earlier, the limma package uses value of
p1 = 0.01, rather than an estimate.) Figure 6 shows
that when p1 = 0.05 lemma tends to slightly over-
estimate the parameter, while the other methods
tend to underestimate it. This is in agreement with
the observation that lemma achieves higher accu-
racy, and has a slightly higher FDR. We also point
out that both estimation methods available in the
locfdr package not only underestimate p1, but also
give unreasonable (negative) estimates. The lemma
estimation procedure is significantly better than the
other three for higher values of p1, even when the
data are generated under the LIMMA model.
6. EXAMPLES
Using the lemma software, we fitted the LEMMA
model to several microarray data sets. For illustra-
tion purposes, we provide our analysis of two pub-
licly available, two-channel gene expression microar-
ray data sets that were previously analyzed: the
ApoA1 data (Callow et al., 2000) and the Colon
Cancer data (Alon et al., 1999).
6.1 ApoA1 Data
The ApoA1 experiment (Callow et al., 2000) used
gene targeting in embryonic stem cells to produce
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Fig. 6. Estimates of p1 when the data are generated under the LEMMA model (top) and under LIMMA (bottom), when the
true values of p1 are 0.05 (left) and 0.25 (right).
mice lacking apolipoprotein A-1, a gene known to
play a critical role in high density lipoprotein (HDL)
cholesterol levels. Originally, 5600 expressed sequence
tags (EST) were selected. In our analysis, we used
the data and normalization method provided with
the limma R package (Smyth, 2005), which consists
of 5548 ESTs, from 8 control (wild type “black six”)
mice and 8 “knockout” (lacking ApoA1) mice. Com-
mon reference RNA was obtained by pooling RNA
from the control mice, and was used to perform ex-
pression profiling for all 16 mice. Note that the cur-
rent version of the limma user’s guide refers to a
larger data set which contains 6384 ESTs. Qualita-
tively speaking, using the larger data set does not
yield different results (in terms of detecting signifi-
cant genes).
The response of interest, yijg, is the log2 fluores-
cence ratio (with respect to the common reference)
where g is one of 5548 genes, j = 1, . . . ,8 (mouse
number), and i is the population index (control and
knockout). Using the EM algorithm, we obtained es-
timates for the parameters in our LEMMA model.
Figure 7(a) depicts the histogram of the 5548 dg
statistics. The smooth black curve shows the fit-
ted mixture distribution, drawn using the average
estimated error variance. The smooth blue and red
curves correspond to the average fitted distributions
of the null and non-null groups, respectively. Per-
gene fitted distributions are plotted in light colors
(note that the non-null probability is very small, so
only gene-specific distributions of the null group, in
light blue, can be observed in this case). The mean-
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Fig. 7. (a) Histogram of the 5548 dg statistics from the ApoA1 data set and the fitted distributions. (b) The Ben-
jamini–Hochberg adjusted p-values for all genes. Using an FDR level of 0.2, we detect 25 non-null genes. (c) Histogram
of the mg statistics and the fitted distribution. (d) The RR test statistics of all the genes. Using a 0.2 threshold for the
posterior probability, we declare 9 genes to be non-null.
effect parameter estimates we obtained are τˆ = 0.007
and ψˆ = 0.682, σˆ2ψ = 0.874.
Figure 7(c) depicts the histogram of themg statis-
tics and the fitted distribution. The estimates for the
shape and scale parameters of the error variance dis-
tribution are 1.87 and 11.11, respectively. The em-
pirical mean and variance of {σ˜2ε,g} are 0.078 and
0.004.
Using the lemma package, we obtained the param-
eter estimates, and computed the gene-specific pos-
terior probabilities and the p-values for the hypothe-
ses that genes are in the null group. Figure 7(b)
depicts the Benjamini–Hochberg adjusted p-values.
The red, solid points represent the genes that were
declared non-null, using a (liberal) FDR threshold of
0.2. Using the FDR criteria, we detected 25 non-null
genes.
Using the posterior probabilities derived from the
LEMMA (RR) model and Efron’s 0.2 threshold for
local f.d.r., we detected 9 non-null genes, including
the ApoA1 gene and others that are closely related
to it. The top eight genes had local f.d.r. values
of nearly zero, while the ninth had a much higher
value of 0.08. Figure 7(d) depicts the RR local f.d.r.
statistics, and the red, solid points represent the
genes that were declared non-null using a local f.d.r.
threshold of 0.2. The top eight genes (using either
the FDR or the local f.d.r. criteria) are also iden-
tified (among others) when using the limma and
locfdr R packages, and were confirmed to be differ-
entially expressed in the knockout versus the control
line by an independent assay.
Interestingly, assuming no other genes are in the
non-null group, the true value of p1 is 0.00144, and
the estimate obtained from lemma is 0.0039, while
Efron’s estimates using the MLE and CME meth-
ods are −0.036 and −0.083, respectively. As we men-
tioned earlier, by default the limma R package does
not provide an estimate for p1, and uses a value of
0.01. However, using the convest function, limma
provides the estimate p1 = 0.30. When one uses the
larger ApoA1 data set currently referred to by the
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limma user’s guide (with 6384 ESTs), the estimate
for p1 is 0.134.
6.2 Colon Cancer Data
The data analyzed by Alon et al. (1999) consists
of 2000 ESTs in 40 tumor and 22 normal colon
tissue samples. Of the 40 patients involved in the
study, 22 supplied both tumor and normal tissue
samples. In their analysis, Alon et al. (1999) used
an Affymetrix oligonucleotide array complementary
to more than 6500 human genes and expressed se-
quence tags (ESTs), and a two-way clustering method
to identify families of genes and tissues based on ex-
pression patterns in the data set. Do, Mu¨ller and
Tang (2005) used a Bayesian mixture model to ana-
lyze the same data set and estimated the probabil-
ity of differential expression. Using empirical Bayes
methods, they obtained a point estimate pˆ0 = 0.39
and contrasted it with the posterior marginal prob-
ability distribution of p0 from the nonparametric
Bayesian model, which they fit using MCMC sim-
ulations. The empirical Bayes estimate for p0 was
far out in the right tail of the posterior distribution,
which, they argued, might lead to underestimating
the posterior probability of being in the non-null
group (differentially expressed genes). They propose
using posterior expected FDR (Genovese andWasser-
man, 2002) thresholds to calibrate between a desired
false discovery rate and the number of significant
genes. For example, with FDR = 0.2, they find 1938
non-null genes.
Using lemma and assuming the two-group LEMMA
model, we obtain pˆ1 = 0.36. According to this model,
the (non-null) mean effect of the gene-specific term
is estimated by ψˆ =−0.04 (and the variance by σˆ2ψ =
0.24), and the fitted two-group mixture distribu-
tion is shown in Figure 8(a). The near-zero mean
of the non-null mixture component suggests that
there may be two non-null groups (over- and under-
expressed groups of genes). We fitted the three-group
variant of the LEMMA model to the data, and ob-
tained pˆ1 = 0.22, pˆ2 = 0.12, and ψˆ =−0.33, σˆ2ψ = 0.15
[see Figure 8(b)]. In Figure 8(a) and (b) the light
blue and purple curves represent the (per gene) fit-
ted distributions for the null and non-null groups,
respectively. The smooth black curve shows the fit-
ted mixture distribution, drawn using the average
estimated error variance.
The three-group model allows for asymmetry in
the proportions of over- and under-expressed genes.
We see no reason to assume that these proportions
should be equal. However, we find in simulations
that if they are indeed equal, our procedure esti-
mates them accurately. We have observed that if the
true model has two non-null groups, then estimating
it assuming two modes results in an estimate of ψ
that is biased toward 0 and an inflated σˆ2ψ (as seen
in this case), and that this could lead to fewer true
discoveries.
In this data set, the empirical mean and variance
of mg are 1.00 and 0.17, respectively, with estimates
αˆ = 10.42 and βˆ = 0.11. Figure 8(c) shows the his-
togram of the mg statistics and the fitted distribu-
tion.
The “volcano plot” in Figure 8(d) depicts the pos-
terior null probability of genes based on the three-
group LEMMA model versus the dg statistics. Us-
ing the null posterior probability threshold of 0.2,
we detect 170 non-null genes, while using the FDR
method (with a threshold of 0.2) we get 155 genes.
Detecting non-null genes in a typical microarray gene
expression analysis involves setting a minimum fold-
change threshold, in addition to setting the level at
which the False Discovery Rate is controlled. For
instance, requiring that |dg| ≥ 1 and controlling the
False Discovery Rate at 0.1, we detect 61 non-null
genes, all of which were detected by at least one
method in Su et al. (2003).
7. DISCUSSION
In the previous sections we demonstrated that our
modeling framework can lead to six different test
statistics depending on the assumptions imposed on
the gene-specific effects. Interestingly, the test statis-
tics associated with these models have been consid-
ered independently in the literature in various forms,
but to our knowledge, this is the first time they
have been categorized as special cases of the same
model. The LEMMA (RR) model, in which both
the non-null gene-specific effects and gene-specific
variances are modeled as random variates, leads to
James–Stein-type (shrinkage) estimation of the pa-
rameters. Specifically, the statistics derived from the
RR model enjoy shrinkage in both the numerator
and denominator of a posterior t-statistic, result-
ing in powerful test statistics while maintaining few
false positives in our simulation studies. Using a
Laplace approximation to make the EM algorithm
tractable, our approach yields stable parameter es-
timates, even for the notoriously difficult parame-
ter p1.
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Fig. 8. Histograms of the 2000 dg statistics from the Alon et al. (1999) data set and the fitted distributions, assuming (a)
a two-group model, or (b) three-group model. (c) Histogram of the mg statistics and the fitted distribution. (d) Volcano plot,
showing the posterior null probabilities by dg.
Since our approach is model-based, it can be eas-
ily generalized to other situations. For example, as
stated earlier, the methods described in this pa-
per can be extended to deal with multiple treat-
ments, paired tests (one group) and multiple non-
null components. Furthermore, it is straightforward
to add fixed-effect covariates to the model. We are
currently working on the next release of the lemma
package which will include this feature, in addition
to within-group analysis, new plotting and export-
ing functions, and confidence intervals for parameter
estimates. Extending the model to handle multivari-
ate responses is also being investigated.
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APPENDIX
In this section we provide details on some of our
previous derivations, and elaborate on the case of
multiple treatments.
A.1 Empirical Bayes Estimates for α and β
To obtain an estimate of the error variance in the
random error case, recall that
mg|σ2ε,g ∼
σ2ε,g
fg
χ2fg ≡Gamma
(
fg
2
,
2σ2ε,g
fg
)
.(19)
We maximize the marginal density of mg numer-
ically to obtain maximum likelihood estimates of α
and β. Given the conditional distribution in (19),
we find the marginal density of mg by integrating
out σ2ε,g. Specifically,
f(mg) =
∫
∞
0
f(mg|σ2ε,g)f(σ−2ε,g)dσ−2ε,g
=
∫
∞
0
[
m
fg/2−1
g exp(−mgfg/(2σ2ε,g))
Γ(fg/2)(2σ2ε,g/fg)
fg/2
]
·
[
exp(−σ−2ε,gβ−1)
Γ(α)βα
(σ−2ε,g )
α−1
]
dσ−2ε,g
=
m
fg/2−1
g (fg/2)
fg/2
Γ(fg/2)Γ(α)βα
(20)
·
∫
∞
0
(σ−2ε,g)
fg/2+α−1
· exp
[
−σ−2ε,g
(
mgfg
2
+
1
β
)]
dσ−2ε,g
=
m
fg/2−1
g (fg/2)
fg/2
Γ(fg/2)Γ(α)βα
· Γ(fg/2 +α)
(mgfg/2 + 1/β)fg/2+α
.
The final equality in (20) results from noting that
the integral in the third equality is proportional to
a Gamma(fg/2 + α, [β
−1 +mgfg/2]
−1) density. We
maximize
∑
g log(f(mg)) with respect to α and β to
obtain the empirical Bayes estimates αˆ and βˆ.
The joint distribution of mg and σε,g is given by
f(mg, σ
−2
ε,g ) =m
fg/2−1
g f
fg/2
g (σ
−2
ε,g )
α−1+fg/2
· exp
{
−σ−2ε,g
[
mg
2
fg +
1
β
]}
/(
Γ
(
fg
2
)
2fg/2Γ(α)βα
)
.
So, conditional on mg,
σ−2ε,g ∼Gamma(α+ fg/2, (mgfg/2 + 1/β)−1).
Hence, the conditional expectation is
E(σ2ε,g|mg)
=
fg/2
fg/2 + α− 1mg +
α+ 1
fg/2 +α− 1 ·
1
(α+1)β
≈ fg/2
fg/2 + α− 1mg +
α+ 1
fg/2 +α− 1m¯,
and the conditional mode is
Mode(σ2ε,g|mg)
=
fg/2
fg/2 + α+1
mg +
α+ 1
fg/2 +α+ 1
· 1
(α+1)β
≈ fg/2
fg/2 + α+1
mg +
α+ 1
fg/2 +α+ 1
m¯.
Note that using the approximation of the mode,
m¯ ≈ [(α + 1)β]−1, in both the posterior mean and
posterior mode yields a shrinkage-estimator form.
Equivalently, we could replace (α+ 1) with (α− 1)
in the conditional expectation and the conditional
mode, and obtain shrinkage toward the sample mean
of {mg}.
A.2 Maximum Likelihood Estimation of φ
Recall that in the RR method we use the Laplace
approximation (8), hence, the (approximate) com-
plete likelihood is
L˜C(φ)
∝
G∏
g=1
L(bg, dg; σ˜
2
g)
=
G∏
g=1
∫
L(bg;p1)L(dg|bg;ψg, σ˜2g)
· f(ψg|bg)dψg
(21)
=
G∏
g=1
[
p
bg
1 (1− p1)1−bg (2πσ˜2g)−1/2
· (2πσ2ψ)−bg/2 exp
{
−1− bg
2σ˜2g
(dg − τ)2
}
·
∫
exp
{
− bg
2σ˜2g
(dg − τ − ψg)2
− bg
2σ2ψ
(ψg − ψ)2
}
dψg
]
,
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with log-likelihood
ℓ(φ)∝
G∑
g=1
[(1− bg) log(1− p1) + bg log(p1)]
−
G∑
g=1
[
bg
2
log(2πσ2ψ) +
1
2
log(2πσ˜2g)
]
− 1
2
G∑
g=1
bg log
(
(2π)−1
(
1
σ˜2g
+
1
σ2ψ
))
(22)
−
G∑
g=1
(1− bg)(dg − τ)
2
2σ˜2g
−
G∑
g=1
bg
2
[
1
σ2ψ + σ˜
2
g
(dg − τ −ψ)2
]
.
The estimates (11)–(14) are obtained by maximiz-
ing the log-likelihood with respect to the parame-
ters, φ.
Although the Laplace approximation is not neces-
sary in the RF and RH models, note that the com-
plete likelihoods and log-likelihoods for the these
models are identical to equations (21) and (22), with
σ˜2g replaced by σˆ
2
g and σˆ
2
ε (as defined in Section 3.2),
respectively.
A.3 Multiple Treatments
In the general case we assume t≥ 2 treatments i=
1,2, . . . , t assigned to t groups of n1,g, n2,g, . . . , nt,g
subjects indexed by j1 = 1, . . . , n1,g, . . . , jt = 1, . . . ,
nt,g, and we use the model defined by (1) and (2).
Here, we impose a standard (fixed effect) constraint
t∑
i=1
ψig = 0.
The distributions for the gene-specific effects in the
multiple-treatment case are assumed to follow a nor-
mal distribution,
ψg ∼ i.i.d. Nt(ψ, σ2ψ(It − J¯t)),
where It − J¯t is the t × t centering matrix, ψ is a
t-dimensional vector, and σ2ψ is a scalar. The test
statistic mg is defined as
mg =
t∑
i=1
nig∑
j=1
(yijg − y¯i·g)2/fg,
where fg = n1g + · · · + ntg − t, and we use mg as
before, to estimate α and β.
To estimate the rest of the parameters in the LEMMA
model, we use the (t − 1-dimensional vector) test
statistics
dg =HY¯g,
where
H=


1/
√
2 −1/√2 0
1/
√
6 1/
√
6 −2/√6
...
...
...
1/
√
t(t− 1) 1/
√
t(t− 1) 1/
√
t(t− 1)
· · · 0
· · · 0
...
· · · −(t− 1)/
√
t(t− 1)

 ,
Y¯g = (Y¯1·g, Y¯2·g, . . . , Y¯t·g)
′.
Derivations similar to the ones we used to obtain
the estimates in Section 3 lead to the same estimate
for p1 and to the following estimates, analogous to
(12) and (13):
(Hτ (m+1))′
=
[
G∑
g=1
p
(m)
0,g d
′
gΛ
−1
0
][
G∑
g=1
p
(m)
0,g Λ
−1
0
]
−1
,
(Hψ(m+1))′
=
[
G∑
g=1
p
(m)
1,g (dg −Hτ (m+1))′(Λ0 +ΛA)−1
]
·
[
G∑
g=1
p
(m)
1,g (Λ0 +ΛA)
−1
]
−1
,
where
ΛA = σ
2(m)
ψ It−1,
Λ0 = σ˜
2
ε,gH[diagi(1/nig)]H
′.
The update for σ˜2ψ is the solution to the equation,
G∑
g=1
p
(m)
1,g · tr((Λ0 +ΛA)−1)
=
G∑
g=1
p
(m)
1,g (dg −Hξ(m+1))′(Λ0 +ΛA)−2
· (dg −Hξ(m+1)),
where ξ(m+1) = τ (m+1) +ψ(m+1).
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The likelihood ratio test statistic has a similar
form as (17),
L0,g
L1,g
= |I−Λg|−1/2 exp
{
−1
2
Γ
′(Λ−10 Λ
−1
g )Γ
}
· exp
{
−1
2
σ˜−2ψ (Hψˆ)
′(Hψˆ)
}
,
where
Γ= [Λg(dg −Hτˆ ) + (I−Λg)(Hψˆ)],
Λg = (ΛA +Λ0)
−1
ΛA,
I−Λg = (ΛA +Λ0)−1Λ0.
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